Measuring the level of neurofilaments in the blood may be a reliable biomarker for the early diagnosis of ALS.
Some coronavirus patients exhibit clinical and neurochemical signs of brain injury associated with the viral infection. COVID-19 patients who required ventilation had increased plasma NfL levels. The higher NfL concentration levels were linked to the severity of infection.
Researchers have identified proteins in the blood that could reflect nerve cell damage.
